ORG Wealth Partners
DMRA icon

ORG Wealth Partners’s Damora Therapeutics DMRA Stock Holding History

ORG Wealth Partners’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$191 Buy
+9
New +$254 ﹤0.01% 2363

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $189B AUM 37.1% 1-Year Est. Return

ORG Wealth Partners's DMRA Position: Q3 2026 in Review

ORG Wealth Partners opened a new position in Damora Therapeutics (DMRA) in Q3 2026: 9 shares worth $191. The stake represents ﹤0.01% of the portfolio and ranks #2363 among its holdings.

37 funds tracked by Wall St. Rank hold DMRA as of Q3 2026.

  • ORG Wealth Partners held 9 shares of Damora Therapeutics worth $191 as of Q3 2026.
  • Damora Therapeutics was a new ORG Wealth Partners position in Q3 2026.
  • Damora Therapeutics made up ﹤0.01% of ORG Wealth Partners's portfolio in Q3 2026, its #2363 holding.
  • 37 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2026.

Based on ORG Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.